Objective: To investigate the use of a biologic TNF-alpha inhibitor, etanercept was given by perispinal extrathecal administration for the treatment of AD. Methods: This was a prospective ...

CASE REPORT: To report a rare case of optic neuropathy in refractory neurosarcoidosis treated with tumour necrosis factor-alpha antagonist (infliximab) perfusion. A 41-year-old man with diabetes ...

A study by Michigan Medicine researchers has investigated possible genetic factors for drug efficacy for children with ...

the first medically useful tumor necrosis factor antagonist. You have full access to this article via your institution. The isolation and identification of the TNF and lymphotoxin proteins and ...

but the integrin receptor antagonist vedolizumab slightly edged out the tumor necrosis factor (TNF) blocker in some areas, according to a real-world dataset. At 52 weeks, there was no significant ...

Given the need to keep his gastrointestinal symptoms under control, he was given adalimumab, a recombinant human IgG1 monoclonal TNF antagonist, starting with an induction course of 160 mg ...

BALTIMORE--(BUSINESS WIRE)--TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“TNFA” or the “Company”), a clinical stage biopharmaceutical company committed to developing novel oral therapies for ...